Adverse Drug Reaction Reporting in the UKA Retrospective Observational Comparison of Yellow Card Reports Submitted by Patients and Healthcare Professionals

被引：0
|
作者：
David J. McLernon
Christine M. Bond
Philip C. Hannaford
Margaret C. Watson
Amanda J. Lee
Lorna Hazell
Anthony Avery
机构：
[1] University of Aberdeen,Medical Statistics Team, Section of Population Health
[2] Drug Safety Research Unit,undefined
[3] Nottingham University Medical School,undefined
来源：
Drug Safety | 2010年 / 33卷
关键词：
Healthcare Professional; Adverse Drug Reaction; Adverse Drug Reaction Reporting; Suspect Drug; System Organ Class;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: In the UK, spontaneous reporting of suspected adverse drug reactions (ADRs) by healthcare professionals has been in operation since 1964 through the Yellow Card Scheme (YCS). From 2005, patients themselves have been able to submit Yellow Card reports.
引用
下载
收藏
页码：775 / 788
页数：13
相关论文
共 50 条
  • [21] Knowledge of Adverse Drug Reaction Reporting and the Pharmacovigilance of Biological Medicines: A Survey of Healthcare Professionals in Ireland
    O'Callaghan, J.
    Griffin, B. T.
    Morris, J. M.
    Bermingham, Margaret
    BIODRUGS, 2018, 32 (03) : 267 - 280
  • [22] Healthcare Professionals' Attitudes towards Adverse Drug Reaction Reporting in Nepal: A Factor Analytic Study
    Santosh, K. C.
    Tragulpiankit, Pramote
    Gorsanan, Sarun
    Edwards, I. Ralph
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 210 - 210
  • [23] Knowledge of adverse drug reaction reporting and the pharmacovigilance of biological medicines: A survey of healthcare professionals in Ireland
    O'Callaghan, J.
    Griffin, B. T.
    Moore, U.
    Morris, J. M.
    Bermingham, M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 12 - 12
  • [24] Survey of Healthcare Professionals on Adverse Drug Reaction Reporting, Communication, and Medicines Regulation in New Zealand
    Chan, L.
    Kenyon, S.
    DRUG SAFETY, 2019, 42 (10) : 1213 - 1213
  • [25] Analysis of Spontaneous Adverse Drug Reaction (ADR) Reports from the Yellow Card Scheme (YCS) in 2010
    Jadeja, M. M.
    Surl, S.
    Foy, M.
    Gandhi, S.
    Cumber, S.
    DRUG SAFETY, 2011, 34 (10) : 1014 - 1014
  • [26] Interventions to improve spontaneous adverse drug reaction reporting by healthcare professionals and patients: systematic review and meta-analysis
    Paudyal, Vibhu
    Al-Hamid, Abdullah
    Bowen, Matthew
    Hadi, Muhammad Abdul
    Hasan, Syed Shahzad
    Jalal, Zahraa
    Stewart, Derek
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (09) : 1173 - 1191
  • [27] Changes in suspected adverse drug reaction reporting via the yellow card scheme in Wales following the introduction of a National Reporting Indicator
    Deslandes, Paul N.
    Bracchi, Robert
    Jones, Karen
    Haines, Kath E.
    Carey, Emma
    Adams, Alana
    Walker, Jenna
    Thomas, Alison
    Routledge, Philip A.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (08) : 3829 - 3836
  • [28] Can adverse drug reactions be detected earlier? A comparison of reports by patients and professionals
    Egberts, TCG
    Smulders, M
    deKoning, FHP
    Meyboom, RHB
    Leufkens, HGM
    BRITISH MEDICAL JOURNAL, 1996, 313 (7056): : 530 - 531
  • [29] Knowledge and attitude of healthcare professionals toward adverse drug reaction reporting system in Saudi Arabia.
    Alqahtani, Zuhair
    Almoslem, Mohammed
    Alowais, Shuroug
    Aljadhey, Hisham
    Alshammari, Thamir
    PHARMACOTHERAPY, 2013, 33 (10): : E298 - E298
  • [30] Awareness, knowledge, and attitude toward adverse drug reaction (ADR) reporting among healthcare professionals in Ghana
    Yawson, Abena Ahwianfoa
    Abekah-Nkrumah, Gordon
    Okai, Grace Adjei
    Ofori, Charles Gyamfi
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2022, 13
12345